Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.9900 (-11.84%) ($4.9900 - $4.9900) on Wed. May. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.28% (three month average) | RSI | 25 | Latest Price | $4.9900(-11.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -7.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(46%) ARKK(43%) IBB(43%) ARKG(42%) XAR(40%) | Factors Impacting ATRA price | ATRA will decline at least -2.64% in a week (0% probabilities). VIXM(-38%) VXX(-25%) UNG(-17%) USO(-11%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.64% (StdDev 5.28%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-15.79(-416.43%) | Resistance Level | $6.93 | 5 Day Moving Average | $6.02(-17.11%) | 10 Day Moving Average | $6.41(-22.15%) | 20 Day Moving Average | $6.93(-27.99%) | To recent high | -66.8% | To recent low | 0% | Market Cap | $371m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |